4th International Ayurveda Cardiology Symposium was organised in Azerbaijan by nearly 200 Ayurveda practitioners from across the world.
Baku, June 02, 2022: After tasting success back home in treating and reversing chronic cardiac-related ailments through its scientific evidence-based Ayurveda therapies, Madhavbaug, the brand of Vaidya Sane Ayurved Laboratories Ltd is now taking this unique treatment method abroad. Led by its founder and CEO Dr Rohit Sane, Madhavbaug organised the 4th International Ayurved Cardiology Symposium at Baku, Azerbaijan which saw participation from nearly 200 Ayurveda practitioners from across the world.
Dr Rohit Sane was the chief guest at the event and facilitated 49 Ayurveda practitioners for practicing evidence-based treatment in the field of chronic cardiac and metabolic disorders. On the occasion, Dr Sane also released a souvenir of evidence-based research papers on the same subject.
“The Indian Ayurveda is one of the oldest indigenous systems of medicine and practice to heal the whole body and mind. While Ayurveda has survived through the ages, the true potential of our traditional system of treatment is yet to get unlocked. We strongly believe that our scientific evidence-based Ayurveda is going to change the way people approach Ayurveda. In coming years, we are confident of putting Indian Ayurveda on top of the global map,” said Dr Rohit Sane, MBBS and fellowship in preventive cardiology.
The two-day event held recently saw Ayurveda cardiac specialist from Madhavbaug presenting 49 research papers on various chronic cardiac ailments and case studies supported by clinical data about ayurvedic management of those cardiometabolic disorders. Some of the topic covered during the course of the event includes heart failure with preserved LVEF, congestive cardiac failure, chronic ischemic heart disease, high cholesterol, hypertension, Post MI management, management of DM retinopathy and management of diabetic wound with Ayurveda treatment principles.
Under Dr Sane’s leadership, Madhavbaug has so far published over 150 research reports in peer-reviewed allopathic medical journals – nationally and globally highlighting its success in treating and reversing lifestyle disorders like diabetes, cardiovascular disease, hypertension and obesity.
Earlier this month, Madhavbaug organised a four-day National Ayurved Cardiology Symposium – the first of its kind in India to promote scientific evidence-based Ayurveda. The event brought together over 5,000 doctors from across India including practitioners of modern medicines.
Corporate Comm India (CCI Newswire)
